Wood Betony for Anxiety and Nervous Tension

Modern herbalists describe wood betony’s calming effect as “grounding” — bringing a racing mind back down into the body. This page checks that broader nervous-system claim against the literature, and runs into something more specific and more useful than a simple absence of evidence: a case of mistaken botanical identity, in which a different plant with a similar name genuinely has been tested in humans, and it is not wood betony.


Table of Contents

  1. The “Grounding” Claim — What It Means in Herbal Practice
  2. What a Species-Locked Search Actually Returns
  3. The Compound-Level Case: Verbascoside and Stachydrine
  4. A Case of Mistaken Identity: Persian Mountain Tea Is Not Wood Betony
  5. What Real Anxiolytic-Herb Evidence Looks Like
  6. Folk Use in the Record: A 2019 Ethnobotany Note
  7. Safety Considerations Specific to Nervous-System Use
  8. The Honest Verdict
  9. Key Research Papers
  10. Connections

The “Grounding” Claim — What It Means in Herbal Practice

Distinct from the specific headache indication covered on this page’s sibling article, betony’s broader nervine reputation is a general one: a mild, everyday herb for anxiety, nervous tension, and a mind that will not settle, gentler and less sedating than a strong relaxant like valerian. Western herbal manuals describe it as suited to someone who feels wound-up or scattered rather than someone who cannot sleep at all — a herb for the day, not specifically for the night. This is a real, describable clinical picture, and the question this page asks is the same one the headache article asks: what happens when that picture is checked against a species-locked search of the modern literature?

Back to Table of Contents


What a Species-Locked Search Actually Returns

Using the same phrase-locked, title/abstract-scoped search described on the headache page — "Stachys officinalis"[tiab] OR "Betonica officinalis"[tiab], restricted to fields PubMed does not silently expand across its taxonomy tree — and adding anxiety-related terms (anxiety[tiab] OR anxiolytic[tiab] OR sedative[tiab] OR "central nervous system"[tiab]) returns exactly two records out of the plant’s entire 19-record indexed literature.

Neither is a study of betony’s effect on anxiety. The first is the U.S. National Institutes of Health’s own LactMed drug-and-lactation database entry for betony, which states in a single background sentence that the plant “has been used as a nerve tonic to treat anxiety and headaches” — a description of the tradition, not a report of a study. The second, discussed in more detail below, is a 2019 survey of ethnoveterinary folk medicine. A dedicated search for depression or antidepressant activity of the species itself returns zero records, and a search for cognitive or memory effects returns zero as well. As with the headache claim, the honest summary is not “limited evidence” — it is no human or animal study of Stachys officinalis itself has tested its effect on anxiety, mood, or cognition, in the indexed literature as it currently stands.

Back to Table of Contents


The Compound-Level Case: Verbascoside and Stachydrine

What does exist is pharmacology of two named compounds betony contains, studied mostly outside the context of betony itself. Both need to be labeled as compound-level evidence, not herb-level evidence, at the point they are cited — not once in a preamble that a reader arriving mid-page or sharing a single fact will never see.

Verbascoside (acteoside)

Betony’s signature phenylethanoid glycoside has documented antioxidant, anti-inflammatory, and neuroprotective pharmacology reviewed comprehensively in 2014, and more recent work specifically describes verbascoside as a neuroprotective phenylethanoid glycoside with anti-depressive properties in preclinical models. Verbascoside occurs across dozens of plant families, and the great majority of this pharmacology was generated using verbascoside isolated from other sources (olive leaf, plantain, and various ornamental and medicinal plants are common sources in the literature), studied in cell culture or in rodents at doses achieved by injection or concentrated extraction — not from steeping betony leaves in hot water. It is real pharmacology of a real compound betony contains. It is not a study of betony.

Stachydrine

Betony also contains the betaine alkaloid stachydrine (proline betaine), which a 2020 review found has documented cardiovascular and anti-inflammatory pharmacology, and more recent work explores its potential against metabolic syndrome and associated organ dysfunction. Stachydrine is named for the genus Stachys, but the overwhelming majority of its pharmacology — and essentially all of the cardiovascular work specifically — comes from motherwort (Leonurus cardiaca), a mint-family relative where stachydrine is the principal marker compound and is present in far higher concentration. Betony containing stachydrine does not transfer motherwort’s pharmacology to betony; it means the two plants share one alkaloid among many other compounds that differ.

Taken together, this compound-level chemistry is a legitimate reason betony’s calming reputation is plausible. It is not evidence that betony works, and the gap between those two words is exactly what the rest of this page is about.

Back to Table of Contents


A Case of Mistaken Identity: Persian Mountain Tea Is Not Wood Betony

Here is the most important finding on this page, and it is a warning rather than a benefit. There is a plant with real, substantial, modern human-trial evidence for anxiolytic effects — and it is not this one. Stachys lavandulifolia Vahl, known in Iran as “Mountain Tea” (چای کوهی), is a different species in the same genus, native to Iran and neighboring regions, used in Persian traditional medicine specifically as an anxiolytic. Because it shares the genus name Stachys — the same genus wood betony belongs to — and because English-language secondary sources sometimes translate its Persian folk name loosely, it is genuinely easy for this species’ real evidence to migrate, uncredited, onto a page about wood betony. It should not.

The literature on Stachys lavandulifolia is not thin. It includes:

The two plants are not close substitutes botanically or traditionally. Wood betony is a European meadow and woodland-edge plant with a documented history running through Roman, Anglo-Saxon, and English herbal medicine. Stachys lavandulifolia is a plant of the Iranian plateau with its own distinct traditional-medicine lineage. They share a genus and, in casual English usage, the risk that “a Stachys species was shown to reduce anxiety in a trial” gets reported as if it applies to whichever Stachys the reader already had in mind. It does not. If a source describes a clinical trial of betony for anxiety, the first thing worth checking is which Stachys it actually used.

SpeciesCommon NameRegion / TraditionHuman Trial Evidence
Stachys officinalis (syn. Betonica officinalis)Wood betonyEurope; Roman, Anglo-Saxon, English herbal medicineNone found
Stachys lavandulifoliaPersian Mountain TeaIran; Persian traditional medicineRandomized trial in emergency medical technicians (occupational stress)
Stachys byzantinaLamb’s earCaucasus / Iran to Turkey; mostly ornamental in the WestNone found; recent preclinical skin-inflammation research (see the safety sub-article)

Back to Table of Contents


What Real Anxiolytic-Herb Evidence Looks Like

To calibrate expectations, here is what genuine modern trial evidence for a calming herb looks like, using herbs already linked from betony’s own traditional blending partners:

Wood betony does not appear as a subject in any of these reviews. That absence, from reviews specifically built to survey this exact question across the whole field of herbal medicine, is itself informative: betony is not an obscure herb these reviews simply missed, it is a herb without a clinical literature for them to include.

Back to Table of Contents


Folk Use in the Record: A 2019 Ethnobotany Note

One genuinely modern, English-language, on-species record is worth noting for what it is and is not. A 2019 ethnoveterinary survey documenting medicinal plants used for pets and wild animals taken into temporary care in British Columbia, Canada, lists Stachys officinalis among more than forty plants recorded as traditionally used for heart problems in pets, alongside hawthorn, motherwort, valerian, and mistletoe. This is not a trial and not a test of any outcome — it is a 2003 interview-based ethnobotanical record, published in 2019, documenting that betony’s reputation as a calming, heart-and-nerve-supportive herb persisted into contemporary folk veterinary practice on a different continent, centuries after it left the European medical mainstream. It demonstrates the reputation’s durability, not its accuracy.

Back to Table of Contents


Safety Considerations Specific to Nervous-System Use

Back to Table of Contents


The Honest Verdict

Wood betony’s reputation as a calming, grounding nervine rests entirely on tradition and on compound-level pharmacology of verbascoside and stachydrine studied mostly outside the plant itself. No study of any kind — human or animal — has tested wood betony’s effect on anxiety. The clearest, most useful finding this search turned up is not about betony at all: a different, related plant with a similar name and a real anxiolytic trial literature exists, and conflating the two is the single most likely way this page’s subject ends up looking better-evidenced than it is. Anyone encountering a citation for a Stachys species and anxiety should check which species before repeating the claim.

Back to Table of Contents


Key Research Papers

  1. Betony. In: Drugs and Lactation Database (LactMed). National Institute of Child Health and Human Development; 2006–. Revised 2024. — PubMed
  2. Cheng F, et al. A review of pharmacological and pharmacokinetic properties of stachydrine. Pharmacological Research. 2020;155:104755. — PubMed
  3. Stachydrine, a pyrrole alkaloid with promising therapeutic potential against metabolic syndrome and associated organ dysfunction. RSC Medicinal Chemistry. 2024. — PubMed
  4. Alipieva K, Korkina L, Orhan IE, Georgiev MI. Verbascoside—a review of its occurrence, (bio)synthesis and pharmacological significance. Biotechnology Advances. 2014;32(6):1065–1076. — PubMed
  5. Zhao Y, Wang S, Pan J, Ma K. Verbascoside: a neuroprotective phenylethanoid glycoside with anti-depressive properties. Phytomedicine. 2023;120:155027. — PubMed
  6. Jadidi A, Irannejad B, Salehi M, Safarabadi M. Effect of Stachys lavandulifolia on occupational stress in emergency medical technicians. Explore. 2023;19(6):803–805. A different species — see the mistaken-identity section above. — PubMed
  7. Anxiolytic effects of Stachys lavandulifolia Vahl on the elevated plus-maze model of anxiety in mice. Journal of Ethnopharmacology. 2003. A different species. — PubMed
  8. Pharmacological and toxicological profile of Stachys lavandulifolia Vahl: a comprehensive review. Zeitschrift für Naturforschung C. 2025. A different species. — PubMed
  9. Kennedy DO, et al. Anxiolytic effects of a combination of Melissa officinalis and Valeriana officinalis during laboratory induced stress. Phytotherapy Research. 2006. — PubMed
  10. Lemon balm (Melissa officinalis L.) on depression and anxiety in clinical trials: a systematic review and meta-analysis. Phytotherapy Research. 2021. — PubMed
  11. Brock C, Whitehouse J, Tewfik I, Towell T. American Skullcap (Scutellaria lateriflora): a randomised, double-blind placebo-controlled crossover study of its effects on mood in healthy volunteers. Phytotherapy Research. 2014. — PubMed
  12. Lans C. Do recent research studies validate the medicinal plants used in British Columbia, Canada for pet diseases and wild animals taken into temporary care? Journal of Ethnopharmacology. 2019;236:366–392. — PubMed

Back to Table of Contents


Connections

Back to Table of Contents